TCIM
IDIX

TIAA CREF Investment Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

TIAA CREF Investment Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-445,926
Closed -$10.7M – 3163
2014
Q2 		$10.7M Buy
445,926
+54,019
+14% +$563K 0.01% 1105
2014
Q1 		$2.36M Sell
391,907
-5,500
-1% -$38.4K ﹤0.01% 2138
2013
Q4 		$2.38M Sell
397,407
-5,773
-1% -$26.7K ﹤0.01% 2148
2013
Q3 		$2.1M Sell
403,180
-5,533
-1% -$24.2K ﹤0.01% 2169
2013
Q2 		$1.48M Buy
+408,713
New +$1.67M ﹤0.01% 2343

TIAA CREF Investment Management's IDIX Position: Q3 2014 in Review

TIAA CREF Investment Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 445,926 shares — an estimated $10.7M sold.

TIAA CREF Investment Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $10.7M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • TIAA CREF Investment Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • TIAA CREF Investment Management sold 445,926 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $10.7M.
  • TIAA CREF Investment Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • TIAA CREF Investment Management's IDENIX PHARMACEUTICALS INC position peaked at $10.7M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on TIAA CREF Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.